EJ
Errol James Desouza
About Errol James Desouza
Data last updated:
Errol James Desouza has 28 years in corporate governance. Holds Partner and Director roles. Currently with 10 companies, including Curatas Pharmaceuticals Llp and Medibest Investments Private Limited. Formerly with 3 companies. Engaged in General Business. Contributes to corporate operations. The 9 current companies with reported revenue have a combined latest revenue of ₹1,352 Cr; the largest is Franco-Indian Pharmaceuticals Private Limited at ₹989 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Franco-Indian Pharmaceuticals Private Limited U24239MH1959PTC011347 | Director | 01 Mar 2023 | 1959 | ₹989 Cr (FY 2024) | Active |
 Laboratoires Griffon Private Limited U24239WB1947PTC015405 | Director | 14 Jan 2025 | 1947 | ₹161 Cr (FY 2024) | Active |
| Wardex Pharmaceuticals Private Limited U51397TN1946PTC005759 | Director | 28 Jan 2025 | 1946 | ₹158 Cr (FY 2025) | Active |
| Franco-Indian Remedies Private Limited U24230TN1973PTC011763 | Director | 13 Jan 2025 | 1973 | ₹33.65 Cr (FY 2024) | Active |
| Princeps Pharmaceuticals Private Limited U24230TN2000PTC073993 | Director | 15 Jan 2025 | 2000 | ₹7.24 Cr (FY 2024) | Active |
| Franco Indian Research Private Limited U93090TN1973PTC010295 | Director | 16 Jan 2025 | 1973 | ₹2.30 Cr (FY 2024) | Active |
| Franco Indian Medicare Pvt Ltd U24231WB1983PTC036434 | Director | 14 Jan 2025 | 1983 | ₹60.1 Lakh (FY 2024) | Active |
| Franco Indian Therapeutics Pvt. Ltd U24232WB1986PTC040635 | Director | 16 Jan 2025 | 1986 | ₹41.4 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Medibest Investments Private Limited U65990MH1983PTC029142 | Director | 29 Dec 1997 | 1983 | – | Amalgamated |
| Pharmabest Investments Private Limited U65990MH1983PTC029143 | Director | 30 Mar 2009 | 1983 | – | Amalgamated |
| Curabest Investments Private Limited U65990MH1983PTC029184 | Director | 10 Dec 2004 | 1983 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Errol James Desouza
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Errol James Desouza
Errol James Desouza has 28 years in corporate governance. Holds Partner and Director roles. Currently with 10 companies, including Curatas Pharmaceuticals Llp and Medibest Investments Private Limited. Formerly with 3 companies. Engaged in General Business. Contributes to corporate operations. The 9 current companies with reported revenue have a combined latest revenue of ₹1,352 Cr; the largest is Franco-Indian Pharmaceuticals Private Limited at ₹989 Cr (FY 2024).
Errol James Desouza is associated with 10 companies as Partner and Director, including Franco-Indian Pharmaceuticals Private Limited (₹989 Cr), Laboratoires Griffon Private Limited (₹161 Cr), Wardex Pharmaceuticals Private Limited (₹158 Cr).
Errol James Desouza has expertise in General Business.
Errol James Desouza has 28 years in corporate governance.
By reported revenue, the largest current company of Errol James Desouza is Franco-Indian Pharmaceuticals Private Limited, with revenue of ₹989 Cr (FY 2024).
The 9 current companies of Errol James Desouza that report revenue have a combined latest revenue of ₹1,352 Cr.
Errol James Desouza currently holds positions at 10 companies; the 5 largest by reported revenue are Franco-Indian Pharmaceuticals Private Limited (₹989 Cr), Laboratoires Griffon Private Limited (₹161 Cr), Wardex Pharmaceuticals Private Limited (₹158 Cr), Franco-Indian Remedies Private Limited (₹33.65 Cr), Princeps Pharmaceuticals Private Limited (₹7.24 Cr).